Health
CanSinoBIO files application in China for COVID-19 vaccine approval – Devdiscourse
“The efficacy of Ad5-nCoV has met the relevant technical standards laid out by the World Health Organization and relevant standards and requirements set out …by…
CanSino Biologics Inc (CanSinoBIO) said on Wednesday it has filed an application in China for approval of its COVID-19 vaccine to become the country’s third locally developed shot allowed for use by the general public.
While China has yet to approve rival vaccines developed by Western drug makers, it has granted authorization to domestic products that have also gained ground in many developing countries battling a surge in coronavirus infections. CanSinoBIO said interim analysis of data from its…
-
Noosa News20 hours agoJazz festival wraps up | Noosa Today
-
Noosa News15 hours agoDog owners warned: $834 fine for pets not under control
-
Noosa News17 hours agoPharmacist’s stolen image used in ‘dangerous’ deepfake adverts for weight loss drug
-
Business19 hours ago5 things to watch on the ASX 200 on Thursday 4 September 2025